Confronting the Silent Threat: Antimicrobial Resistance in Upper
Respiratory Tract Infections
Abstract
Objectives - This comprehensive study investigates the diverse
bacterial species responsible for upper respiratory tract infections,
their impact on different age groups, clinical diagnoses, and antibiotic
resistance patterns. Design -A prospective analysis was
conducted to uncover the intricate connections between various bacterial
infections and their corresponding effects on a large patient
population. Setting -The study’s methodology involved thorough
clinical assessments to monitor respiratory diseases, culminating in the
classification of bacteria and their microbial growth
Participants :- . Of the 1,003 participants, 514 were found to
be infected, with the 16-39 age group being the most affected. The
primary clinical diagnoses included acute tonsillopharyngitis, acute
tonsillitis, acute pharyngitis and acute laryngitis . Main
outcome measures :- The findings underscore the respiratory system’s
susceptibility to infection due to its exposure to airborne
microorganisms. Results :- Analysis of 1,003 cases revealed
that Streptococcus mitis had the highest infection rate across all age
groups, particularly in cases of cold cough and sore throat. Other
common bacteria identified were Streptococcus parasanguinis and
Streptococcus sanguinis. The study aimed to assess the susceptibility of
these infectious microorganisms to various medications, with Vancomycin,
linezolid, and bacitracin exhibiting 100% sensitivity, while
carbimoxazole displayed the highest resistance at 84%.
Methicillin-resistant Staphylococcus aureus was identified as the most
resistant strain, with a maximum resistance of 57.86% against all
tested medications. Conclusion : This comprehensive
investigation provides valuable insights into the relationship between
infection and bacterial strain resistance, paving the way for the
development of new therapeutic strategies.